# OnCo record peter-borchmann (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/peter-borchmann/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "peter-borchmann" ;
  schema:name "Peter Borchmann"@en ;
  schema:description "Leads the German Hodgkin Study Group and HD21, which made BrECADD the most effective and least toxic regimen for advanced Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/people/peter-borchmann/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Borchmann%20P%5BAuthor%5D%20Hodgkin> ;
  onco:tag "hodgkin", "ghsg", "trialist" ;
  schema:jobTitle "Professor of Medicine and Head of the German Hodgkin Study Group, University Hospital Cologne" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/fdg-pet/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:companies <https://onco.cc/companies/ghsg/> ;
  onco:institutions <https://onco.cc/institutions/uniklinik-koeln/> ;
  onco:trials <https://onco.cc/trials/hd21/> ;
  schema:affiliation <https://onco.cc/institutions/uniklinik-koeln/> .